Loading…

Laborie Medical Technologies completed its tender offer for Cogentix Medical at $3.85 per share, acquiring approximately 84.5% of outstanding shares. The merger is expected to close on April 23, 2018, making Cogentix a wholly owned subsidiary.
“LABORIE Medical Technologies announced the successful completion of the tender offer by its affiliate Camden Merger Sub, Inc. to purchase all outstanding shares of common stock of Cogentix Medical, Inc.”laborie.com
Summarized from public sources; check the original articles before acting on it.